Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

James R. Lupski; Carol A. Wise; Akira Kuwano; Liu Pentao; Julie T. Parke; Daniel G. Glaze; David H. Ledbetter; Frank Greenberg; Pragna I. Patel

doi:10.1038/ng0492-29

Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

James R. Lupski, Carol A. Wise, Akira Kuwano, Liu Pentao, Julie T. Parke, Daniel G. Glaze, David H. Ledbetter, Frank Greenberg, Pragna I. Patel

Research output: Contribution to journal › Article › peer-review

254 Scopus citations

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.

Original language	English (US)
Pages (from-to)	29-33
Number of pages	5
Journal	Nature genetics
Volume	1
Issue number	1
DOIs	https://doi.org/10.1038/ng0492-29
State	Published - Apr 1992

ASJC Scopus subject areas

Genetics

Access to Document

10.1038/ng0492-29

Cite this

@article{43f9e2beb673491a8398b4a879516679,

title = "Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A",

abstract = "Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.",

author = "Lupski, {James R.} and Wise, {Carol A.} and Akira Kuwano and Liu Pentao and Parke, {Julie T.} and Glaze, {Daniel G.} and Ledbetter, {David H.} and Frank Greenberg and Patel, {Pragna I.}",

year = "1992",

month = apr,

doi = "10.1038/ng0492-29",

language = "English (US)",

volume = "1",

pages = "29--33",

journal = "Nature genetics",

issn = "1061-4036",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

AU - Lupski, James R.

AU - Wise, Carol A.

AU - Kuwano, Akira

AU - Pentao, Liu

AU - Parke, Julie T.

AU - Glaze, Daniel G.

AU - Ledbetter, David H.

AU - Greenberg, Frank

AU - Patel, Pragna I.

PY - 1992/4

Y1 - 1992/4

N2 - Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.

AB - Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.

UR - http://www.scopus.com/inward/record.url?scp=0026849499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026849499&partnerID=8YFLogxK

U2 - 10.1038/ng0492-29

DO - 10.1038/ng0492-29

M3 - Article

C2 - 1301995

AN - SCOPUS:0026849499

SN - 1061-4036

VL - 1

SP - 29

EP - 33

JO - Nature genetics

JF - Nature genetics

IS - 1

ER -

Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this